Abstract:Since 2020, the REACh regulation requires toxicological data on nanoforms of materials, including the assessment of their skin-sensitizing properties. Small molecules' skin sensitization potential can be assessed by new approach methodologies (NAMs) addressing three key events (KE: protein interaction, activation of dendritic cells, and activation of keratinocytes) combined in a defined approach (DA) described in the OECD guideline 497. In the present study, the applicability of three NAMs (DPRA, LuSens, and h-CLAT) to nine materials (eight inorganic nanomaterials (NM) consisting of CeO2, BaSO4, TiO2 or SiO2, and quartz) was evaluated. The NAMs were technically applicable to NM using a specific sample preparation (NANOGENOTOX dispersion protocol) and method modifications to reduce interaction of NM with the photometric and flowcytometric read-outs. The results of the three assays were combined according to the defined approach described in the OECD guideline No. 497; two of the inorganic NM were identified as skin sensitizers. However, data from animal studies (for ZnO, also human data) indicate no skin sensitization potential. The remaining seven test substances were assessed as "inconclusive" because all inorganic NM were outside the domain of the DPRA, and the achievable test concentrations were not sufficiently high according to the current test guidelines of all three NAMs. The use of these NAMs for (inorganic) NM and the relevance of the results in general are challenged in three ways: (i) NAMs need modification to be applicable to insoluble, inorganic matter; (ii) current test guidelines lack adequate concentration metrics and top concentrations achievable for NM; and (iii) NM may not cause skin sensitization by the same molecular and cellular key events as small organic molecules do; in fact, T-cell-mediated hypersensitivity may not be the most relevant reaction of the immune system to NM. We conclude that the NAMs adopted by OECD test guidelines are currently not a good fit for testing inorganic NM.

How to resolve inconclusive predictions from defined approaches for skin sensitisation in OECD Guideline No. 497

Skin Sensitisation Case Study: Comparison of Defined Approaches including OECD 497 Guidance

Integrated skin sensitization assessment based on OECD methods (II): Hazard and potency by combining kinetic peptide reactivity and the "2 out of 3" Defined Approach

Potency classification of isothiazolinone compounds based on defined approaches of skin sensitization in OECD GL 497

Computational application of internationally harmonized defined approaches to skin sensitization: DASS App

Development of an in silico evaluation system that quantitatively predicts skin sensitization using OECD Guideline No. 497 ITSv2 defined approach for skin sensitization classification

Performance of the DASF compared to other combinations of OECD NAMs for eye hazard identification of surfactants

Use of human predictive patch test (HPPT) data for the classification of skin sensitization hazard and potency

Development of a novel in vitro respiratory sensitization assay and its application in an integrated testing strategy (ITS)

Improved Defined Approaches for Predicting Skin Sensitization Hazard and Potency in Humans

In Silico Prediction of Skin Sensitization for Compounds Via Flexible Evidence Combination Based on Machine Learning and Dempster-Shafer Theory

Borderline Range Determined Using Data From Validation Study of Alternative Methods for Skin Sensitization: ADRA, IL‐8 Luc Assay, and EpiSensA

Increasing Accessibility of Bayesian Network-Based Defined Approaches for Skin Sensitisation Potency Assessment

Predicting points of departure and potency categories for fragrance ingredients by integrating OECD in vitro models

Hybrid optimal descriptors as a tool to predict skin sensitization in accordance to OECD principles

In Vitro Prediction of Skin-Sensitizing Potency Using the GARDskin Dose–Response Assay: A Simple Regression Approach

Deriving a Continuous Point of Departure for Skin Sensitization Risk Assessment Using a Bayesian Network Model

Limitations and Modifications of Skin Sensitization NAMs for Testing Inorganic Nanomaterials

In Vitro Dendritic Cell-Based Test for Skin Sensitizers Identification and Potency Estimation

A Novel Machine Learning Model and a Web Portal for Predicting the Human Skin Sensitization Effects of Chemical Agents

Deriving a Point of Departure for Assessing the Skin Sensitization Risk of Wearable Device Constituents with In Vitro Methods